ACB News《澳华财经在线》8月31日讯 生物制药公司Mesoblast(ASX:MSB)周二发布公告称,2021财年销售额下降77%至750万美元,净亏损扩大至9880万美元。 该公司表示,关于使用restemcell – L药物治疗与新冠病毒相关的急性呼吸窘迫综合征,FDA建议公司完成另一项临床研究。 ( 图片来源:《澳华财经在线》) 公告发布后,Mesobla...
ACB News《澳华财经在线》11月22日讯 总部位于墨尔本的生物制药公司Mesoblast(ASX:MSB)周一发布公告称,已同意与洛杉矶基金管理公司 Oaktree Capital Management 达成一项 9000 万美元的债务融资协议,以偿还现有的债务融资,并帮助公司在美国市场扩张。 公告表示,这笔款项的三分之二已用于偿还 Hercules Capital 现有的优先...
Mesoblast Limited (ASX:MSB) Single Dose Of Proprietary Adult Stem Cells Regenerates Damaged Pancreas And Reduces Blood Glucose Levels In DiabetesAsia Business News
Mesoblast Limited (ASX:MSB) Announce Long-Lasting and Sustained Effect by Allogeneic Cells In Knee Osteoarthritis Preclinical TrialsAsia Business News
Mesoblast Limited (ASX:MSB) FDA Grants Orphan Drug Designation For Use Of Proprietary Stem Cells In Bone Marrow TransplantsAsia Business News
Mesoblast Limited (ASX:MSB) - Strong Progress Continues With Adult Stem Cell Therapy in Several ApplicationsAsia Business News
Mesoblast Limited (ASX:MSB) Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusion SurgeryAsia Business News
Mesoblast Limited (ASX:MSB) First Patients Treated With Adult Stem Cells For Congestive Heart FailureAsia Business News
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) Stem Cells Regrow Knee Cartilage In Severe Post-Menopausal OsteoarthritisAsia Business News
Mesoblast Limited (ASX:MSB) Announce Positive Results Of Novel Heart Attack Treatment Presented At Premier USA Cardiology ConferenceAsia Business News